Results 251 to 260 of about 2,599,480 (386)

Generation of Novel Monoclonal Antibodies Recognizing Rabbit CD34 Antigen. [PDF]

Biomolecules
Vašíček J, Bauer M, Kontseková E, Baláži A, Svoradová A, Dujíčková L, Tvrdá E, Vozaf J, Supuka P, Chrenek P.   +9 more
europepmc   +1 more source

The antigenic structure and topography of bacteriorhodopsin in purple membranes as determined by interaction with monoclonal antibodies [PDF]

, 1985
Yu.A. Ovchinnikov, N.G. Abdulaev, Р. Г. Василов, Iryna Y. Vturina, Alexander Kuryatov, Anton Kiselev   +5 more
openalex   +1 more source

Strategies to Improve the Lipophilicity of Hydrophilic Macromolecular Drugs

Advanced Healthcare Materials, EarlyView.
Hydrophilic macromolecular drugs can be successfully lipidized by covalent attachment of lipids, by hydrophobic ion pairing with negatively or positively charged surfactants, and by dry or wet reverse micelle formation. Lipophilicity enhancement of hydrophilic macromolecules has several benefits including stability and bioavailability improvement ...
Sera Lindner, Stefan Keim, Soheil Haddadzadegan, Odile Fernandez Romero, Katrin Zöller, Gabriel Stern, Ilaria Cesi, Krum Kafedjiiski, Andreas Bernkop‐Schnürch   +8 more
wiley   +1 more source

Real World Effectiveness and Tolerability of Novel Monoclonal Antibodies and Rituximab for NMOSD. [PDF]

Ann Clin Transl Neurol
Javed Z, Du M, Rensel M, Hua LH, Hersh CM, Abbatemarco JR, Conway DS, Ontaneda D, Cohen JA, Kunchok A.   +9 more
europepmc   +1 more source

Selective inhibition of growth factor-dependent human B cell proliferation by monoclonal antibody AB1 to an antigen expressed by activated B cells. [PDF]

, 1984
Lawrence Jung, Shu Man Fu
openalex   +1 more source

Advances in Photonic Materials and Integrated Devices for Smart and Digital Healthcare: Bridging the Gap Between Materials and Systems

Advanced Materials, EarlyView.
This article summarizes significant technological advancements in materials, photonic devices, and bio‐interfaced systems, which demonstrate successful applications for impacting human healthcare via improved therapies, advanced diagnostics, and on‐skin health monitoring.
Seunghyeb Ban, Hoon Yi, Jaejin Park, Yunuo Huang, Ki Jun Yu, Woon‐Hong Yeo   +5 more
wiley   +1 more source

Expression and immmunogenicity of HLA-B27 in high-transfection recipient P815: [PDF]

, 1989
Kuon, W., Riethmüller, Gert, Thureau, S. R., Weiss, Elisabeth H., Wildner, G.   +4 more
core   +1 more source

Bi‐Functional Topospecific Nanoparticles to Promote Immune‐Tumor Cell Engagement as A New Immunotherapeutic Strategy

Advanced Materials, EarlyView.
A Janus‐engineered nanoplatform (J‐pHLIP‐PD1), featuring separate tumor‐ and immune‐targeting faces, bridges melanoma cells and cytotoxic T lymphocytes using toposelective pHLIP and anti‐PD‐1 presentation. This strategy elicits robust antitumor responses, promotes immunogenic tumor cell death, suppresses lung metastasis in vivo, and provides a modular,
Alba Ortuño‐Bernal, Sandra Clara‐Trujillo, Elena Lucena‐Sánchez, Francisco J. Hicke, Andrea Escudero, Sandra Pradana‐López, Nelia Jiménez‐Alduan, Paula Díez, Alba García‐Fernández, Ramón Martínez‐Máñez   +9 more
wiley   +1 more source

Inhibitory activities of monoclonal antibodies against <i>Staphylococcus aureus</i> clumping factor A. [PDF]

mBio
Banerjee B, Emolo C, Shi M, Al Fardan AA, Pius T, Azam MS, McAdow M, Schneewind O, Missiakas D.   +8 more
europepmc   +1 more source

A multiplicity of erythrocyte glycolipids of the neolacto series revealed by immunothin-layer chromatography with monoclonal anti-I and anti-i antibodies [PDF]

, 1983
K Uemura, RA Childs, P Hanfland, T Feizi
openalex   +1 more source